There are 2789 resources available
471P - Prognostic role of preoperative direct bilirubin-to-indirect bilirubin ratio and neutrophils-to-lymphocytes in resectable colorectal cancer
Presenter: Yifei Ma
Session: ePoster Display
472P - Characterizing the anal microbiome in proximal versus distal colorectal cancer
Presenter: Soham Ali
Session: ePoster Display
473P - A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
Presenter: Akihito Kawazoe
Session: ePoster Display
522P - Risk mitigation of ocular toxicities due to antibody drug conjugates (ADCs) in novel early-phase clinical trials
Presenter: Khobe Chandran
Session: ePoster Display
1540P - Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study
Presenter: Margaret von Mehren
Session: ePoster Display
1541P - Real-world data from patients with gastrointestinal stromal tumors (GIST) treated in Dutch GIST expertise centers
Presenter: Nikki IJzerman
Session: ePoster Display
1542P - Kaposi sarcoma: A population-based study of secondary primary neoplasms
Presenter: Gabriel Hanna
Session: ePoster Display
Resources:
Abstract
1596P - SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
Presenter: Anna Pous
Session: ePoster Display
1544P - Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations
Presenter: Tom Wei-Wu Chen
Session: ePoster Display
1545P - Initial presentation of sarcomas in adult patients from private and public health insurance systems in Brazil: A single center analysis
Presenter: Celso Filho
Session: ePoster Display